Elite Pharmaceuticals Inc /Nv/ Sample Contracts

March 16th, 2006 · Common Contracts · 1000 similar
Elite Pharmaceuticals Inc /De/EX-10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of March 15, 2006 among Elite Pharmaceuticals, Inc., a Delaware corporation (the "COMPANY"), and the several purchasers signatory...
March 16th, 2006 · Common Contracts · 531 similar
Elite Pharmaceuticals Inc /De/ARTICLE I DEFINITIONS
July 9th, 2020 · Common Contracts · 372 similar
Elite Pharmaceuticals Inc /Nv/REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 8, 2020, by and between ELITE PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

July 9th, 2020 · Common Contracts · 133 similar
Elite Pharmaceuticals Inc /Nv/PURCHASE AGREEMENT

PURCHASE AGREEMENT (the “Agreement”), dated as of July 8, 2020, by and between ELITE PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).

July 23rd, 2007 · Common Contracts · 39 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of July 17, 2007 among Elite Pharmaceuticals, Inc., a Delaware corporation (the "COMPANY"), and the several purchasers...
November 15th, 2013 · Common Contracts · 31 similar
Elite Pharmaceuticals Inc /Nv/RIGHTS AGREEMENT by and between ELITE PHARMACEUTICALS, INC. and American Stock Transfer & Trust Company, LLC as Rights Agent Dated as of November 15, 2013

THIS RIGHTS AGREEMENT, dated as of November 15, 2013 (the “Agreement”), is by and between Elite Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Rights Agent”).

April 22nd, 2013 · Common Contracts · 14 similar
Elite Pharmaceuticals Inc /Nv/PURCHASE AGREEMENT

PURCHASE AGREEMENT (the “Agreement”), dated as of April 19, 2013, by and between ELITE PHARMACEUTICALS, INC., a Nevada corporation, (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).

January 5th, 2012 · Common Contracts · 7 similar
Elite Pharmaceuticals Inc /De/SECURITIES PURCHASE AGREEMENT

Please execute this letter in the space indicated to acknowledge your agreement to act in accordance with these instructions. Should you have any questions concerning this matter, please contact [______________].

March 3rd, 2000 · Common Contracts · 4 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS AGREEMENT is entered into this 28th day of December 1995, by and between Elite Laboratories, Inc., a Delaware corporation (hereinafter "ELITE") and Atul M. Mehta of Ramsey, New Jersey (hereinafter "MEHTA")....
March 3rd, 2000 · Common Contracts · 4 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.2 BRIDGE VENTURES, INC. 1241 Gulf of Mexico Dr. Longboat Key, Florida 34228 CONSULTING AGREEMENT THE CONSULTING AGREEMENT ("Agreement") is made this 1st day of August 1997, by and between Bridge Ventures, Inc.] (the "Consultant") whose...
December 20th, 2005 · Common Contracts · 4 similar
Elite Pharmaceuticals Inc /De/THE SECURITIES REPRESENTED BY THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF (THE "SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR WITH ANY STATE SECURITIES COMMISSION, AND...
March 3rd, 2000 · Common Contracts · 4 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.3 SAGGI CAPITAL CORP. 545 Madison Avenue New York New York 10022 CONSULTING AGREEMENT THE CONSULTING AGREEMENT ("Agreement") is made this 1st day of August 1997, by and between Saggi Capital Corp. (the "Consultant") whose principal place of...
March 3rd, 2000 · Common Contracts · 3 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.5 CONFIDENTIALITY AGREEMENT - CORPORATION CONFIDENTIALITY AGREEMENT NON-DISCLOSURE AGREEMENT Elite Laboratories, Inc. of 230 W. Passaic Street, Maywood, New Jersey 07607, a Delaware corporation (hereinafter referred to as "ELITE") have in...
October 12th, 2004 · Common Contracts · 3 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.12 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of October 6, 2004, by and among Elite Pharmaceuticals, Inc., a Delaware corporation (the "Company"), Indigo Securities, LLC (the "Placement Agent"),...
February 10th, 2020 · Common Contracts · 3 similar
Elite Pharmaceuticals Inc /Nv/EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT

THIS LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT is made as of March 6, 2019 (the “Effective Date”), by and between ELITE PHARMACEUTICALS, INC. a Nevada corporation and ELITE LABORATORIES, INC., Delaware corporation located at 165 Ludlow Avenue, Northvale, New Jersey 07647 (collectively, “ELITE”), and LANNETT COMPANY, INC., USA, a Delaware corporation located at 9000 State Road, Philadelphia, PA 19136 and/or its Affiliates (“LANNETT”).

February 14th, 2007 · Common Contracts · 3 similar
Elite Pharmaceuticals Inc /De/EXECUTION COPY AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "AGREEMENT"), dated February 9, 2007, by and between Elite Pharmaceuticals, Inc., a Delaware corporation ("COMPANY"), and Charan Behl ("EXECUTIVE")....
June 14th, 2021 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/June 21, 2019 Personal and Confidential Douglas Plassche

This letter agreement (the “Agreement”) shall confirm our understanding as to the terms of your continuing employment with Elite Laboratories, Inc., a Delaware corporation (the “Company”).

November 14th, 2013 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/LOAN AGREEMENT

This Loan Agreement (the “Agreement”) is made this 15th day of October, 2013 by and between NASRAT HAKIM, a resident of New Jersey (“Lender”), and: Elite Pharmaceuticals, Inc., a Nevada corporation (“Borrower”), having its executive office in Northvale, New Jersey.

February 17th, 2004 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 10.1 ELITE PHARMACEUTICALS, INC. CONSULTING AGREEMENT CONSULTING AGREEMENT, dated as of November 4th, 2003 (the "Effective Date") between Elite Pharmaceuticals, Inc., a Delaware corporation ("Company"), with offices at 165 Ludlow Avenue,...
November 14th, 2014 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/EMPLOYMENT AGREEMENT

This agreement (“Agreement”) is made on October 20, 2014, by and between Elite Pharmaceuticals, Inc., a Nevada corporation (“Company”), and George Kenneth Smith (“Executive”).

August 9th, 2017 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR PRODUCTS BETWEEN ELITE PHARMACEUTICALS, INC. AND SUNGEN

This DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated July 6, 2017 (the “Effective Date”) between SunGen Pharma LLC, 303C College Road East, Princeton, NJ 08540, USA (SunGen) and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), organized under the laws of the State of Delaware, with offices at 165 Ludlow Avenue, Northvale, New Jersey, USA (“Elite”); SunGen and Elite may sometimes hereinafter be referred to as a “Party” or collectively as the “Parties”.

August 14th, 2003 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/Exhibit 10.11 ------------- STOCK OPTION AGREEMENT ---------------------- This STOCK OPTION AGREEMENT made as of this 23rd day of July, 2003 (this "Agreement"), by and between Elite Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and...
April 26th, 2011 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/ASSET PURCHASE AGREEMENT FOR NALTREXONE HYDROCHLORIDE 50 MG TABLET

THIS ASSET PURCHASE AGREEMENT (“Agreement”), dated August 27, 2010 (the “Effective Date”), is between Mikah Pharma LLC, a limited liability company organized under the laws of Delaware (“Seller”), and Elite Pharmaceuticals, Inc., a publicly traded company organized under the laws of the State of Delaware (“Buyer”).

March 3rd, 2000 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/EXHIBIT 4.2 FORM OF WARRANT AGREEMENT NUMBER WARRANTS ELITE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANTS CUSIP 28659T 127 THIS CERTIFIES THAT _______________ IS THE OWNER OF ___________ OR REGISTERED ASSIGNS, IS ENTITLED TO PURCHASE ONE FULLY...

OR REGISTERED ASSIGNS, IS ENTITLED TO PURCHASE ONE FULLY PAID AND NONASSESSABLE SHARE OF ELITE PHARMACEUTICALS, INC., A DELAWARE CORPORATION (HEREIN CALLED THE COMPANY) FOR EACH WARRANT EVIDENCED BY THIS CERTIFICATE FOR $6.00 PER SHARE DURING THE PERIOD COMMENCING UPON THE FIRST DAY THAT THE COMMON STOCK TRADES AND EXPIRING NOVEMBER 30, 2002, UPON ITS SURRENDER, AND PAYMENT OF THE PURCHASE PRICE AT THE AGENTS OFFICE, 201 BLOOMFIELD AVE., VERONA, NEW JERSEY 07044 SUBJECT TO THE FOLLOWING CONDITIONS: 1. THE EXERCISE PRICE IS PAYABLE IN CASH, CERTIFIED CHECK OR BANK DRAFT; 2. ADJUSTMENTS IN THE EXERCISE PRICE OR NUMBER OF SHARES ISSUABLE WILL BE MADE FOR STOCK SPLITS, RECAPITALIZATION, MERGER, CONSOLIDATION OR OTHER EVENT AFFECTING WARRANT HOLDERS INTEREST, ADJUSTMENTS FOR THE STATED EVENT WILL MAINTAIN THE WARRANT HOLDER'S SAME RELATIVE POSITION TO THE COMPANY AS EXISTED PRIOR TO EXERCISE. 3. WARRANT EXERCISE REQUIRES APPROPRIATE COMPLETION OF THE "ELECTION TO PURCHASE" PRINTED ON THE BA

November 15th, 2010 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/MANUFACTURING AND SUPPLY AGREEMENT

This Manufacturing and Supply Agreement (the "Agreement") is entered into as of the 10th day of September, 2010 (the "Effective Date"), by and between Precision Dose, Inc., an Illinois corporation ("PRECISION DOSE"), and Elite Pharmaceuticals, Inc. and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), both Delaware corporations ("ELITE").

August 13th, 2004 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/WARRANT TO
July 15th, 1998 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of ______, 1997 by and between Prologica International, Inc., a Delaware corporation (the "Company"), and the person whose name appears on the signature page attached hereto...
April 25th, 2014 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/MANUFACTURING AND LICENSE AGREEMENT

This License Agreement (“Agreement”) is entered into as of the 2nd day of October, 2013 by and between EPIC PHARMA LLC, a Delaware limited liability company (“EPIC”), and ELITE PHARMACEUTICALS, INC., a Nevada corporation and ELITE LABORATORIES, INC. (a subsidiary of Elite Pharmaceuticals, Inc.), a Delaware corporation (collectively, “ELITE”).

August 14th, 1998 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/Commercial Lease This lease is made between Serex, Inc., a New Jersey corporation, herein called Landlord and Elite Laboratories of Englewood Cliffs herein called Tenant. Landlord hereby offers to lease to Tenant the premises situated in the City of...

This lease is made between Serex, Inc., a New Jersey corporation, herein called Landlord and Elite Laboratories of Englewood Cliffs herein called Tenant.

August 30th, 2018 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/ASSET PURCHASE AGREEMENT

ASSET PURCHASE AGREEMENT (“Agreement”), dated August 1, 2013 (the “Effective Date”), between Mikah Pharma LLC a limited liability company organized under the laws of the State of Delaware ( “Seller”) and Elite Laboratories, Inc., a corporation incorporated under the laws of the State of Delaware (“Buyer”). Buyer and Seller are each “Party” to this Agreement and together constitute the “Parties”.

June 14th, 2017 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/ANDA SECURITY AGREEMENT

THIS ABBREVIATED NEW DRUG APPLICATION SECURITY AGREEMENT (the “Agreement”), dated as of May 15, 2017, between Elite Laboratories, Inc., a Delaware corporation (“Elite”) and its parent, Elite Pharmaceuticals, Inc., a Nevada corporation (collectively, “Debtors”), and Mikah Pharma LLC, a limited liability company organized under the laws of the State of Delaware ("Secured Party");

February 10th, 2020 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/ASSET PURCHASE AGREEMENT BY AND BETWEEN Elite Pharmaceuticals, Inc. AND NOSTRUM LABORATORIES INC. DATED AS OF November 13, 2019 This document is not intended to create, nor will it be deemed to create, a legally binding or enforceable offer or...

This Asset Purchase Agreement (this “Agreement”), dated as of November 13, 2019, is entered into by and between Elite Pharmaceuticals, Inc., a Nevada corporation (“Seller”), and Nostrum Laboratories Inc., a New Jersey, USA corporation (“Buyer”). Seller and Buyer shall be referred to herein from time to time collectively as the “Parties” and individually as a “Party”. Capitalized words have the definitions set forth in Annex A.

July 11th, 2016 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/LICENSE AGREEMENT Between Elite Pharmaceuticals, Inc. and Epic Pharma LLC

This License Agreement (“Agreement”) is entered into as of the 4th day of June, 2015 by and between EPIC PHARMA LLC, a Delaware limited liability company (“EPIC”) located at 227-15 N. Conduit Avenue, Laurelton, New York 11413 and ELITE PHARMACEUTICALS, INC., a Nevada corporation and ELITE LABORATORIES, INC. (a subsidiary of Elite Pharmaceuticals, Inc.), a Delaware corporation (collectively, “ELITE”) located at 165 Ludlow Avenue, Northvale, New Jersey 07647.

July 23rd, 2007 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /De/ARTICLE I DEFINITIONS
July 31st, 2020 · Common Contracts · 2 similar
Elite Pharmaceuticals Inc /Nv/ASSET PURCHASE AGREEMENT

ASSET PURCHASE AGREEMENT (“Agreement”), dated August 1, 2013 (the “Effective Date”), between Mikah Pharma LLC a limited liability company organized under the laws of the State of Delaware ( “Seller”) and Elite Laboratories, Inc., a corporation incorporated under the laws of the State of Delaware (“Buyer”). Buyer and Seller are each “Party” to this Agreement and together constitute the “Parties”.